Intravenous solutions are fluids with medicines, salts, minerals, vitamins, and more. These solutions are given to replace water, sugar, and salt for a patient living with chronic health conditions. It helps in resolving the imbalance of water in the body and restores normal functions. The IV solution is directly injected in the vein through a drip and requires monitoring.
MARKET DYNAMICS
The intravenous (IV) solutions market growth is estimated to grow due to rising demand by the end-users, growing incidences of chronic diseases, growing pharmaceutical production. The never-ending demand from the hospital segment is expected to serve vital growth opportunities during the forecast period.
MARKET SCOPE
The "Intravenous (IV) Solutions Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of intravenous (IV) solutions market with detailed market segmentation by solution, bag type, and end user. The intravenous (IV) solutions market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in intravenous (IV) solutions market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The intravenous (IV) solutions market is segmented on the basis of, solution, bag type, and end user. Based on solution, the market is divided into saline, dextran, lactated ringer's, amino acid, vitamins and minerals, heparin and trace elements, and mixed solutions. Based on bag type, the market is divided into large volume bags, and small volume bags. And based on end user, the market is classified as hospitals and clinics, ambulatory surgery centers, and home care settings.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the intravenous (IV) solutions market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The intravenous (IV) solutions market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting intravenous (IV) solutions market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the intravenous (IV) solutions market in these regions.
MARKET PLAYERS
The report covers key developments in the intravenous (IV) solutions market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from intravenous (IV) solutions market are anticipated to have lucrative growth opportunities in the future with the rising demand for intravenous (IV) solutions in the global market. Below mentioned is the list of few companies engaged in the intravenous (IV) solutions market.
The report also includes the profiles of key players in intravenous (IV) solutions market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Baxter International Inc.
- ICU Medical, Inc.
- Grifols, S.A.
- B. Braun Melsungen AG
- Fresenius Kabi
- Amanta Healthcare
- JW Life Science
- Soxa Formulations and Research (Pvt.) Ltd
- AXA Parenterals Ltd.
- Otsuka Pharmaceutical Co., Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.